Cullinan Therapeutics, Inc. CGEM Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s accounts payable?
- Cullinan Therapeutics, Inc. (CGEM) reported accounts payable of $2.51M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s accounts payable changed year-over-year?
- Cullinan Therapeutics, Inc.'s accounts payable decreased by 26.2% year-over-year, from $3.4M to $2.51M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s accounts payable?
- Over 4 years (2021 to 2025), Cullinan Therapeutics, Inc.'s accounts payable has grown at a -5.5% compound annual growth rate (CAGR), from $10.58M to $8.43M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.